Clinical Trial Update: Study to Evaluate R2R01 Plus Terlipressin Versus Terlipressin Alone in Patients With Hepatorenal Syndrome [Phase 2]

View source ↗

Summary

Phase 2 clinical trial comparing R2R01 plus terlipressin versus terlipressin alone in patients with hepatorenal syndrome and acute kidney injury.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatorenal Syndrome
• Kidney Injury

Drugs mentioned

• R2R01 (R2R01)
• Terlipressin (terlipressin)

Snippet

Sponsor: River 2 Renal Corp. | Conditions: Hepatorenal Syndrome, Acute Kidney Injury | Phase 2 | Status: UNKNOWN